Back to Search Start Over

A quadrivalent vaccine against serogroup B meningococcal disease : a cost-effectiveness study - Supplement

Authors :
Christensen, Hannah
Agnew Emily
Trotter, Caroline
Robays, Jo
Dubois, Cécile
Devriese, Stephan
Van de Sande, Stefaan
Thiry, Nancy
Hanquet, Germaine
Christensen, Hannah
Agnew Emily
Trotter, Caroline
Robays, Jo
Dubois, Cécile
Devriese, Stephan
Van de Sande, Stefaan
Thiry, Nancy
Hanquet, Germaine
Publication Year :
2014

Abstract

59 p.<br />ill.<br />A. Summary 2 -- B. Introduction 3 -- C. Models, parameters and data sources 3 -- D. Model validation 13 -- E. Results.14 -- E. Strengths and limitations 39 -- F. Conclusions 39 -- Appendix 1. Dynamic model equations, population mixing and estimating the risk of disease given infection 41 -- Appendix 2. Cost‐effectiveness planes for cohort model scenarios.45 -- References 58

Details

Database :
OAIster
Notes :
Study 2012-23 HTA Meningococ Vaccine B, A4, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn946019665
Document Type :
Electronic Resource